Cytek Biosciences Inc

CTKB

Company Profile

  • Business description

    Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

  • Contact

    47215 Lakeview Boulevard
    FremontCA94538
    USA

    T: +1 877 922-9835

    https://www.cytekbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    703

Stocks News & Analysis

stocks

Two cheap wide moat ASX shares

These shares are trading at a discount to our fair value discount and have sustainable competitive advantages.
stocks

Anthropic: Are the shares undervalued given the IPO pricing range?

There may be meaningful upside as Anthropic is pricing its stock as a reflection of current sentiment, not the company’s fundamentals.
stocks

Valuation looks stretched for ASX healthcare share

Strong fundamentals meet a demanding valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,274.2017.10-0.18%
CAC 408,361.3628.490.34%
DAX 4026,771.88109.110.41%
Dow JONES (US)52,488.572.080.00%
FTSE 10010,863.0927.620.25%
HKSE24,008.55307.37-1.26%
NASDAQ25,410.8455.35-0.22%
Nikkei 22560,819.36429.23-0.70%
NZX 50 Index14,259.2379.370.56%
S&P 5007,612.247.14-0.09%
S&P/ASX 2009,146.806.40-0.07%
SSE Composite Index3,655.8324.81-0.67%

Market Movers